Status:

COMPLETED

Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents

Lead Sponsor:

Columbia University

Collaborating Sponsors:

Agency for Healthcare Research and Quality (AHRQ)

Conditions:

Human Papillomavirus

Eligibility:

All Genders

Phase:

NA

Brief Summary

Emerging communication technologies, such as text messaging offer low-cost, scalable opportunities to improve health literacy and promote healthy behaviors, such as vaccination. While the investigator...

Eligibility Criteria

Inclusion

  • Parenting adult of adolescent age 11-17 years
  • Adolescent received 1st dose of HPV at a study site within the last 2 weeks.
  • Eligible parent's cell phone has text message capability

Exclusion

  • Language other than English or Spanish only
  • Parent already in the study
  • Intends to move away from the New York City area in \<12 months

Key Trial Info

Start Date :

December 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2017

Estimated Enrollment :

956 Patients enrolled

Trial Details

Trial ID

NCT02236273

Start Date

December 1 2014

End Date

December 1 2017

Last Update

July 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Columbia University Medical Center

New York, New York, United States, 10032